Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 3, 2025 • 8:31 AM ET

Date/Time Source News Release
05/22/2025 09:30 AM EDT ACCESS Newswire IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market
05/12/2025 09:30 AM EDT ACCESS Newswire IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting
04/24/2025 09:30 AM EDT ACCESS Newswire IGC Pharma Welcomes Strategic Investment from Advisors
04/21/2025 09:30 AM EDT ACCESS Newswire IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs
04/08/2025 09:30 AM EDT ACCESS Newswire IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program
04/01/2025 09:00 AM EDT ACCESS Newswire IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health
03/26/2025 09:00 AM EDT ACCESS Newswire IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances
03/20/2025 09:00 AM EDT ACCESS Newswire IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences
03/17/2025 09:00 AM EDT ACCESS Newswire IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida
03/12/2025 09:00 AM EDT ACCESS Newswire IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25"
Page

Additional News

As of June 3, 2025 • 8:31 AM ET

Date/Time Source News Release
05/30/2025 05:25 PM EDT Zacks Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates
02/18/2025 12:33 PM EST SeekingAlpha IGC Pharma GAAP EPS of -$0.02, revenue of $257M
02/14/2025 05:10 PM EST Zacks IGC Pharma, Inc. (IGC) Reports Q3 Loss, Tops Revenue Estimates
01/28/2025 12:00 PM EST Zacks IGC Pharma, Inc. (IGC) Upgraded to Strong Buy: What Does It Mean for the Stock?
01/08/2025 10:04 AM EST Baystreet IGC Gains on Word of Alzheimer's Treatment
12/18/2024 12:00 PM EST Zacks What Makes IGC Pharma, Inc. (IGC) a New Buy Stock
12/02/2024 09:32 AM EST SeekingAlpha IGC Pharma advances IGC-AD1 as a potential Alzheimer's therapy
11/14/2024 08:43 AM EST SeekingAlpha India Globalization Capital GAAP EPS of -$0.02 beats by $0.01, revenue of $0.41M beats by $0.21M
11/12/2024 06:10 PM EST Zacks FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates
10/13/2024 04:17 AM EDT SeekingAlpha Coya Therapeutics Has Several Near-Term Share Price Appreciation Catalysts
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.